• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通人群中心力衰竭和左心室功能障碍的患病率;鹿特丹研究

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study.

作者信息

Mosterd A, Hoes A W, de Bruyne M C, Deckers J W, Linker D T, Hofman A, Grobbee D E

机构信息

Department of Epidemiology & Biostatistics, Erasmus University and University Hospital Rotterdam Dijkzigt, The Netherlands.

出版信息

Eur Heart J. 1999 Mar;20(6):447-55.

PMID:10213348
Abstract

AIMS

To determine the prevalence of heart failure and symptomatic as well as asymptomatic left ventricular systolic dysfunction in the general population.

METHODS AND RESULTS

In 5540 participants of the Rotterdam Study (age 68.9+/-8.7 years, 2251 men) aged 55-95 years, the presence of heart failure was determined by assessment of symptoms and signs (shortness of breath. ankle oedema and pulmonary crepitations) and use of heart failure medication. In 2267 subjects (age 65.7+/-7.4 years, 1028 men) fractional shortening was measured. The overall prevalence of heart failure was 3.9% (95% CI 3.0+/-4.7) and did not differ between men and women. The prevalence increased with age, with the exception of the highest age group in men. Fractional shortening was higher in women and did not decrease appreciably with age. The prevalence of left ventricular systolic dysfunction (fractional shortening <=25%) was approximately 2.5 times higher in men (5.5%, 95% CI 4.1-7.0) than in women (2.2%, 95% CI 1.4-3.2). Sixty percent of persons with left ventricular systolic dysfunction had no symptoms or signs of heart failure at all.

CONCLUSIONS

The prevalence of heart failure is appreciable and does not differ between men and women. The majority of persons with left ventricular systolic dysfunction can be regarded as having asymptomatic left ventricular systolic dysfunction.

摘要

目的

确定普通人群中心力衰竭以及有症状和无症状左心室收缩功能障碍的患病率。

方法与结果

在鹿特丹研究的5540名年龄在55 - 95岁的参与者(年龄68.9±8.7岁,男性2251名)中,通过评估症状和体征(呼吸急促、脚踝水肿和肺部啰音)以及心力衰竭药物的使用来确定心力衰竭的存在。在2267名受试者(年龄65.7±7.4岁,男性1028名)中测量了缩短分数。心力衰竭的总体患病率为3.9%(95%可信区间3.0±4.7),男性和女性之间无差异。患病率随年龄增加,男性最高年龄组除外。女性的缩短分数较高,且随年龄没有明显下降。左心室收缩功能障碍(缩短分数≤25%)的患病率在男性(5.5%,95%可信区间4.1 - 7.0)中约为女性(2.2%,95%可信区间1.4 - 3.2)的2.5倍。60%的左心室收缩功能障碍患者根本没有心力衰竭的症状或体征。

结论

心力衰竭的患病率相当可观,男性和女性之间无差异。大多数左心室收缩功能障碍患者可被视为患有无症状左心室收缩功能障碍。

相似文献

1
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study.普通人群中心力衰竭和左心室功能障碍的患病率;鹿特丹研究
Eur Heart J. 1999 Mar;20(6):447-55.
2
Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study.75岁男性和女性的左心室收缩功能障碍:一项基于人群的研究。
Eur Heart J. 2001 Apr;22(8):676-83. doi: 10.1053/euhj.2000.2284.
3
[Epidemiology of left ventricular systolic dysfunction in the general population of Germany: results of an echocardiographic study of a large population-based sample].[德国普通人群左心室收缩功能障碍的流行病学:基于大规模人群样本的超声心动图研究结果]
Z Kardiol. 2003 Apr;92(4):294-302. doi: 10.1007/s00392-003-0899-2.
4
Prevalence of asymptomatic left ventricular systolic dysfunction in at-risk medical inpatients.高危内科住院患者无症状左心室收缩功能障碍的流行情况。
Am J Med. 2013 Jan;126(1):68-73. doi: 10.1016/j.amjmed.2012.06.020. Epub 2012 Nov 20.
5
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen.哥本哈根中老年城市人群中左心室收缩功能受损和心力衰竭的患病率
Heart. 2003 Dec;89(12):1422-9. doi: 10.1136/heart.89.12.1422.
6
Association of parental heart failure with risk of heart failure in offspring.父母心力衰竭与子代心力衰竭风险的关联。
N Engl J Med. 2006 Jul 13;355(2):138-47. doi: 10.1056/NEJMoa052948.
7
Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study.澳大利亚老年人中心力衰竭和收缩性心室功能障碍的患病率:堪培拉心脏研究
Med J Aust. 2006 Feb 20;184(4):151-4. doi: 10.5694/j.1326-5377.2006.tb00173.x.
8
Subclinical Abnormalities in Echocardiographic Parameters and Risk of Sudden Cardiac Death in a General Population: The Rotterdam Study.超声心动图参数亚临床异常与一般人群中心脏性猝死的风险:鹿特丹研究。
J Card Fail. 2016 Jan;22(1):17-23. doi: 10.1016/j.cardfail.2015.06.007. Epub 2015 Jun 18.
9
Measures of subclinical cardiac dysfunction and increased filling pressures associate with pulmonary arterial pressure in the general population: results from the population-based Rotterdam Study.在一般人群中,亚临床心功能障碍和充盈压升高的指标与肺动脉压相关:来自基于人群的鹿特丹研究的结果。
Eur J Epidemiol. 2018 Apr;33(4):403-413. doi: 10.1007/s10654-017-0341-0. Epub 2017 Dec 13.
10
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.英格兰超声心动图心脏筛查研究中左心室收缩功能障碍和心力衰竭的患病率:一项基于人群的研究。
Lancet. 2001 Aug 11;358(9280):439-44. doi: 10.1016/s0140-6736(01)05620-3.

引用本文的文献

1
Demographic disparities in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的人口统计学差异。
Heart Fail Rev. 2025 Jul 17. doi: 10.1007/s10741-025-10547-6.
2
Heart failure in Nigeria: protocol for a systematic review and meta-analysis.尼日利亚心力衰竭:系统评价和荟萃分析方案。
Afr Health Sci. 2023 Jun;23(2):530-536. doi: 10.4314/ahs.v23i2.61.
3
The Evolving Role of Vericiguat in Patients With Chronic Heart Failure.维立西呱在慢性心力衰竭患者中不断演变的作用
Cureus. 2023 Dec 1;15(12):e49782. doi: 10.7759/cureus.49782. eCollection 2023 Dec.
4
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials.钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭管理中的作用:心力衰竭试验中临床结局终点面临的持续挑战。
Pharmaceutics. 2023 Mar 29;15(4):1092. doi: 10.3390/pharmaceutics15041092.
5
Motivational Interviewing for Enhancing Self-care in Patients With Heart Failure: Protocol for a Randomized Controlled Trial.动机性访谈对改善心力衰竭患者自我护理的作用:一项随机对照试验方案
JMIR Res Protoc. 2023 Mar 28;12:e44629. doi: 10.2196/44629.
6
The Prevalence and Risk Factors of Chronic Heart Failure in the Mongolian Population.蒙古族人群慢性心力衰竭的患病率及危险因素
Diagnostics (Basel). 2023 Mar 6;13(5):999. doi: 10.3390/diagnostics13050999.
7
Epicardial Fat Volume, Cardiac Function, and Incident Heart Failure: The Rotterdam Study.心外膜脂肪体积、心脏功能与心力衰竭事件:鹿特丹研究。
J Am Heart Assoc. 2023 Jan 3;12(1):e026197. doi: 10.1161/JAHA.122.026197. Epub 2022 Dec 24.
8
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.在普通人群中,晚期糖基化终产物、心脏功能和心力衰竭:鹿特丹研究。
Diabetologia. 2023 Mar;66(3):472-481. doi: 10.1007/s00125-022-05821-3. Epub 2022 Nov 8.
9
Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭患者中行心房颤动消融术的安全性、有效性及预后获益
Arrhythm Electrophysiol Rev. 2022 Apr;11:e18. doi: 10.15420/aer.2022.10.
10
Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure.达格列净在因失代偿性心力衰竭住院的未选择患者中的适用性。
Br J Cardiol. 2021 Apr 22;28(2):18. doi: 10.5837/bjc.2021.018. eCollection 2021.